Dhuwit awis saben lembar saham Scorpius Holdings, Inc (SCPX)

nighthawkbio.com - logo grafis emiten SCPX

Fluctuations in cash per share demonstrate current liquidity, where the parameter value reaches 0.85. The stable cash flow of Scorpius Holdings, Inc. (SCPX) is based on multi-year agreements with major drug developers. The company's high market power is driven by a shortage of biomanufacturing capacity, while expansion into the CDMO segment facilitates the localization of drug production within the US.

Dhuwit awis saben siji saham Scorpius Holdings (SCPX): kanggo periode 21.02.2024 - 26.04.2025

Rincian analitis perusahaan Scorpius Holdings (SCPX)

- indikator anane dhuwit lan arus kas:
Ringkesan analisis perusahaan:Scorpius Holdings, Inc - SCPX
Produk asil prodhuksi nighthawkbio.com

Long-term risk control requires a liquidity assessment to ensure the business's financial stability. For Scorpius Holdings, Inc. (SCPX), this is critical when maintaining expensive equipment and a staff of highly qualified biochemists. The cash per share value is calculated by dividing the total amount of cash by the number of issued shares. This metric demonstrates the real pace of capital accumulation relative to the market price. An increase in this indicator confirms the company's viability, whereas stagnation may indicate a lack of investment in development.